-
341
Overcoming immunosuppression in cancer: how ketogenic diets boost immune checkpoint blockade
Published 2024-11-01Subjects: Get full text
Article -
342
-
343
The probable progression of Epstein-Barr virus (EBV) to chronic active EBV/reactivation weakens the immune response and stimulates Cryptococcus neoformans infection, which invariably proves fatal: a case report and review of the literature
Published 2025-01-01“…We have reported here the fatal outcome of Epstein-Barr virus (EBV) infection in a 58-year-old male who had probably developed reactivation/chronic active EBV (CAEBV) which gave rise to various neurological deficits, pancytopenia, and a lower CD4 count in the patient. The decreased immune response helped Cryptococcus neoformans (C. neoformans) to manifest a disseminated infection. …”
Get full text
Article -
344
A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation
Published 2025-01-01“…NaBiVO3-PEG intratumorally administered initiates robust therapeutic efficacies against both primary and distant tumors and activates systemic immune responses to combat tumor metastasis. NaBiVO3-PEG intravenously administered can efficiently accumulate at the tumor site for further real-time computed tomography monitoring, immunotherapy, or alternative synergistic immune-radiotherapy. …”
Get full text
Article -
345
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster dosesResearch in context
Published 2025-03-01“…Here, we determined and compared in a longitudinal study the immune response elicited by SARS-CoV-2 vaccination across different groups of individuals who are immunocompromised. …”
Get full text
Article -
346
-
347
-
348
The impact of immune cell interactions on virus quasi-species formation
Published 2024-11-01Subjects: Get full text
Article -
349
Identification of the immune infiltration and biomarkers in ulcerative colitis based on liquid–liquid phase separation-related genes
Published 2025-02-01Subjects: Get full text
Article -
350
Host–virus interactions during infection with a wild-type ILTV strain or a glycoprotein G deletion mutant ILTV vaccine strain in an ex vivo system
Published 2025-02-01Subjects: Get full text
Article -
351
Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia
Published 2023-09-01“…This study aims to determine in patients with chronic lymphocytic leukaemia (CLL) if a 3-week pause in Bruton tyrosine kinase inhibitor therapy (BTKi) starting 1 week before delivery of SARS-CoV-2 vaccine booster, improves vaccine immune response when compared with continuation of BTKi.Methods and analysis An open-label, randomised controlled superiority trial will be conducted in haematology clinics in approximately 10 UK National Health Service (NHS) hospitals. …”
Get full text
Article -
352
MODERN TREATMENT OF METASTATIC MELANOMA: FROM STANDARDS TO AN INDIVIDUALIZED APPROACH IN REAL CLINICAL PRACTICE
Published 2018-06-01Subjects: Get full text
Article -
353
T4 Phage Displaying Dual Antigen Clusters Against H3N2 Influenza Virus Infection
Published 2025-01-01Subjects: Get full text
Article -
354
Therapeutic application and potential mechanism of plant-derived extracellular vesicles in inflammatory bowel disease
Published 2025-02-01Subjects: Get full text
Article -
355
Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC
Published 2025-02-01Subjects: Get full text
Article -
356
MicroRNA155 in non-small cell lung cancer: a potential therapeutic target
Published 2025-02-01Subjects: Get full text
Article -
357
A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges
Published 2018-01-01Get full text
Article -
358
A nucleoside-modified mRNA vaccine prevents enterovirus A71 infection in mouse model
Published 2025-02-01Subjects: Get full text
Article -
359
The Effects of the COVID-19 Pandemic on Abnormal Uterine Bleeding According to the PALM-COEIN Classification
Published 2024-12-01Subjects: Get full text
Article -
360
Immunostimulatory Effects of Guanine-Quadruplex Topologies as Scaffolds for CpG Oligodeoxynucleotides
Published 2025-01-01Subjects: Get full text
Article